Search
for
Sort by
Research 241–270 of 1000+
- JAK Inhibitors for Treatment of Alopecia Areata
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- New and Emerging Therapies for Alopecia Areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- A novel therapeutic paradigm for patients with extensive alopecia areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- New drugs under investigation for the treatment of alopecias
- Treating Alopecia Areata: Current Practices Versus New Directions
- Biochemical properties of red tilapia (Oreochromis niloticus) protein hydrolysates.
- Alopecia Areata: An Update on Treatment Options for Children
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- JAK inhibition decreases the autoimmune burden in Down syndrome
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Alopecia areata – Current understanding and management
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata